Association between prehypertension, metabolic and inflammatory markers, decreased adiponectin and enhanced insulinemia in obese subjects

Table 2 The table shows the serum parameter analyses to triglyceride, cholesterol, high-density (HDL), low-density (LDL) and very-low density (VLDL) cholesterol, uric and free fat acids plasma levels from the lean (LS) group, compared with the obese subgroup subjects

	Control	n	Norminsulinemic	n	Hyperinsulinemic	n	P	P¹	P²	P³
	(LS)		(NI)		(HI)			LSvs. NI	LSvs. HI	NIvs. HI
Cholesterol (mg/dl)	169.33 ± 40.08	12	186.64 ± 27.07	14	184.55 ± 15.97	11	ns	0.045	ns	ns
HDL-cholesterol (mg/dl)	35.08 ± 13.31	13	26.50 ± 4.64	14	26.73 ± 8	11	ns	ns	ns	ns
LDL-cholesterol (mg/dl)	113.17 ± 32.31	12	133.67 ± 27.39	15	139.83 ± 24.56	12	0.040	ns	0.015	ns
VLDL-cholesterol (mg/dl)	18.92 ± 6.99	12	21.87 ± 10.28	15	22.91 ± 8.3	11	ns	ns	ns	ns
Triglyceride (mg/dl)	94.92 ± 34.45	12	111.00 ± 50.13	15	114.91 ± 41.06	11	ns	ns	ns	ns
Uric acid (mg/dl)	4.75 ± 1.53	13	4.49 ± 0.89	15	5.25 ± 1.07	11	ns	ns	ns	0.033
Free fatty acids (mg/dl)	382.05 ± 129.80	12	545.11 ± 454.67	14	396.58 ± 97.1	12	ns	ns	ns	ns

Values are means ± DP; P values for comparison between groups by non-parametric analysis of Kruskal Wallis; P, comparing all groups and P¹, P² and P³ comparison between groups.